As we demonstrated when mapping COVID-19 patient data, CD8+ T cells from patients with COVID-19 were separate from IFN-β-treated CD8+ T cells in the global representation obtained from all GPs in UMAP (Fig. 5b,c). This evidence concerns the gene IFNB1 and COVID-19.